Donor-derived malignancy after allogeneic stem cell transplantation: a rare but well recognized complication. Tsirigotis P, Lazana I. Bone Marrow Transplant 2025 Sep 26. doi: 10.1038/s41409-025-02725.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tsirigotis P, Lazana I. Donor-derived malignancy after allogeneic stem cell transplantation: a rare but well recognized complication. Bone Marrow Transplant 2025 Sep 26. doi: 10.1038/s41409-025-02725.
PMID: 41006895